Single-nucleotide polymorphisms (5p15.33, 15q25.1, 6p22.1, 6q27 and 7p15.3) and lung cancer survival in the European Prospective Investigation into Cancer and Nutrition (EPIC).
暂无分享,去创建一个
E. Riboli | P. Vineis | U. Vogel | A. Tjønneland | K. Overvad | N. Wareham | P. Brennan | W. Xun | T. Key | P. Peeters | A. Trichopoulou | F. Canzian | G. Hallmans | K. Khaw | H. Boeing | M. Johansson | R. Kaaks | D. Palli | S. Panico | R. Tumino | M. Kumle | C. Sacerdote | E. Lund | A. Agudo | C. Agnoli | M. Chirlaque | María-José Sánchez | A. Barricarte | L. Arrióla | L. Rodríguez | Erifili Oustoglou | T. Rasmuson | Wei W. Xun | M. Sánchez | H. Bueno-de-Mesquita | Zoi Giotaki | L. Rodríguez | P. Brennan | E. Riboli
[1] B Asselain,et al. Five-year survival for lung cancer patients managed in general hospitals. , 2011, Revue des maladies respiratoires.
[2] R. Catarino,et al. Prognostic Significance of Telomerase Polymorphism in Non–Small Cell Lung Cancer , 2010, Clinical Cancer Research.
[3] J. Cunningham,et al. A Rigorous and Comprehensive Validation: Common Genetic Variations and Lung Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[4] T. Mok,et al. Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis , 2009, Journal of cellular and molecular medicine.
[5] D. Bertrand,et al. Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence. , 2009, Addictive behaviors.
[6] R. Houlston,et al. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. , 2009, Carcinogenesis.
[7] John P. Rice,et al. Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[8] S. Heath,et al. Investigation of the fine structure of European populations with applications to disease association studies , 2008, European Journal of Human Genetics.
[9] Christopher I Amos,et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk , 2008, Nature Genetics.
[10] John P. Rice,et al. A Risk Allele for Nicotine Dependence in CHRNA5 Is a Protective Allele for Cocaine Dependence , 2008, Biological Psychiatry.
[11] Simon Heath,et al. Lung cancer susceptibility locus at 5p15.33 , 2008, Nature Genetics.
[12] Tatiana Foroud,et al. Variants in nicotinic receptors and risk for nicotine dependence. , 2008, The American journal of psychiatry.
[13] L. Bierut,et al. Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with ‘pleasurable buzz’ during early experimentation with smoking , 2008, Addiction.
[14] Susanna M Cramb,et al. The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[15] Stephen Chanock,et al. Population Substructure and Control Selection in Genome-Wide Association Studies , 2008, PloS one.
[16] P. Laurent-Puig,et al. Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma , 2008, BMC Medical Genomics.
[17] R. Ankathil,et al. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India , 2008, Journal of Cancer Research and Clinical Oncology.
[18] G. Mills,et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.
[19] W. Tan,et al. Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis , 2008, Clinical Cancer Research.
[20] Daniel F. Gudbjartsson,et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.
[21] Paolo Vineis,et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.
[22] R. Ankathil,et al. p53 Arg72Pro Polymorphism Predicts Survival Outcome in Lung Cancer Patients in Indian Population , 2008, Cancer investigation.
[23] Hermann Brenner,et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. , 2007, The Lancet. Oncology.
[24] S Beck,et al. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer , 2007, Oncogene.
[25] G. O'Connor,et al. Linkage and association with pulmonary function measures on chromosome 6q27 in the Framingham Heart Study. , 2003, Human molecular genetics.
[26] L. Stitt,et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] L. Cardon,et al. Population stratification and spurious allelic association , 2003, The Lancet.
[28] F. Clavel-Chapelon,et al. European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics , 2002, Public Health Nutrition.
[29] Chenghui Yan,et al. [Genescan analysis of non-small cell lung cancer in the long arm of chromosome 6]. , 2002, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.
[30] N. Rothman,et al. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. , 2000, Journal of the National Cancer Institute.
[31] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[32] Y. Shimosato,et al. Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.
[33] D. Schoenfeld,et al. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. , 1982, Biometrics.
[34] J. Yokota,et al. Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. , 2009, Carcinogenesis.
[35] Bernard Asselain,et al. Survie à cinq ans des cancers bronchiques primitifs dans les centres hospitaliers généraux , 2009 .
[36] H. Brenner,et al. The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study. , 2006, Journal of clinical epidemiology.
[37] T. Bjørge,et al. Prognosis of patients with lung cancer diagnosed in Norway, 1954-93 , 2004, Cancer Causes & Control.